Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world, and its incidence continues to increase each year. Yet, there is still no definitive drug …

The booming prevalence of nonalcoholic fatty liver disease (NAFLD) in adults and children
will threaten the health system in the upcoming years. The “multiple hit” hypothesis is the …

Nonalcoholic fatty liver diseases (NAFLD) represent a set of liver disorders progressing from
steatosis to steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma, which induce …

Nonalcoholic fatty liver disease (NAFLD), which is characterized by excessive fat
accumulation in the liver of patients who consume little or no alcohol, becomes increasingly …

Nonalcoholic fatty liver disease (NAFLD) defines fat accumulation in the liver, and it is
commonly associated with metabolic syndromes like diabetes and obesity. Progressive …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world. Its pathogenesis is closely related to insulin resistance, obesity, type 2 diabetes, and …

Nonalcoholic fatty liver disease (NAFLD) is one of the most commonly occurring diseases
within western dietary patterns. Usually untreated, it may lead to type 2 diabetes mellitus …

Liver disease results from a dynamic pathological process associated with cellular and
genetic alterations, which may progress stepwise to liver dysfunction. Commonly, liver …

By 2025, the projected global obesity rates for both men and women are 18% and 21%,
respectively. Obesity raises the risk of several comorbidities like cardiovascular disease …

Non-alcoholic fatty liver disease (NAFLD) is an accumulation of fat in the liver despite a low
level of alcohol intake, with signs of hepatomegaly. Although in the past, NAFLD was …